Total Payments
$67,165
2024 Payments
$4,103
Companies
26
Transactions
238
Medicare Patients
2,551
Medicare Billing
$461,697
Payment Breakdown by Category
Other$45,750 (68.1%)
Consulting$11,880 (17.7%)
Food & Beverage$5,667 (8.4%)
Travel$3,702 (5.5%)
Education$166.68 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $45,750 | 29 | 68.1% |
| Consulting Fee | $11,880 | 2 | 17.7% |
| Food and Beverage | $5,667 | 176 | 8.4% |
| Travel and Lodging | $3,702 | 17 | 5.5% |
| Education | $166.68 | 14 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $36,871 | 39 | $0 (2021) |
| ABBVIE INC. | $19,409 | 62 | $0 (2024) |
| Indivior Inc. | $7,551 | 23 | $0 (2024) |
| Neuronetics, Inc. | $917.60 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $364.89 | 16 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $352.12 | 17 | $0 (2024) |
| Allergan, Inc. | $338.81 | 16 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $235.69 | 7 | $0 (2021) |
| ITI, Inc. | $159.79 | 9 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $143.65 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,103 | 25 | ABBVIE INC. ($3,880) |
| 2023 | $15,537 | 41 | AbbVie Inc. ($15,412) |
| 2022 | $1,070 | 11 | Neuronetics, Inc. ($902.26) |
| 2021 | $2,663 | 42 | Alkermes, Inc. ($1,911) |
| 2020 | $1,435 | 38 | Alkermes, Inc. ($735.88) |
| 2019 | $21,785 | 42 | Alkermes, Inc. ($19,681) |
| 2018 | $13,968 | 30 | Alkermes, Inc. ($7,976) |
| 2017 | $6,604 | 9 | Alkermes, Inc. ($6,567) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: OUD | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $101.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: NEUROSCIENCE | ||||||
| 07/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/10/2024 | Hikma Pharmaceuticals USA | Kloxxado (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.63 | General |
| Category: PSYCHIATRY | ||||||
| 03/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $20.77 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 614 | 1,839 | $313,858 | $137,625 |
| 2022 | 12 | 879 | 1,998 | $266,845 | $144,605 |
| 2021 | 12 | 615 | 1,450 | $230,714 | $121,314 |
| 2020 | 7 | 443 | 944 | $129,819 | $58,153 |
Total Patients
2,551
Total Services
6,231
Medicare Billing
$461,697
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 970 | $188,130 | $85,068 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 210 | 632 | $81,405 | $37,311 | 45.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 27 | 27 | $6,750 | $3,866 | 57.3% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 17 | 69 | $15,525 | $3,513 | 22.6% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 20 | 38 | $6,650 | $2,693 | 40.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 29 | 30 | $5,741 | $1,911 | 33.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 26 | 45 | $4,365 | $1,759 | 40.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 28 | $5,292 | $1,504 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 824 | $123,600 | $71,083 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 285 | 733 | $73,300 | $47,148 | 64.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 57 | 57 | $14,250 | $6,956 | 48.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 39 | 85 | $15,300 | $4,765 | 31.1% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 30 | 58 | $11,600 | $3,876 | 33.4% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 15 | 41 | $7,175 | $2,452 | 34.2% |
| 90838 | Psychotherapy with evaluation and management visit, 1 hour | Office | 2022 | 13 | 25 | $6,250 | $2,131 | 34.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 32 | 32 | $5,832 | $2,002 | 34.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 23 | 36 | $2,700 | $1,917 | 71.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 12 | $3,051 | $986.61 | 32.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 53 | 74 | $1,850 | $672.10 | 36.3% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Facility | 2022 | 20 | 21 | $1,937 | $616.71 | 31.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 186 | 463 | $69,450 | $43,309 | 62.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 131 | 378 | $37,800 | $23,033 | 60.9% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 23 | 160 | $36,000 | $18,561 | 51.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 76 | 76 | $19,000 | $10,910 | 57.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 116 | $20,352 | $7,010 | 34.4% |
About Dr. Husam Alathari, MD
Dr. Husam Alathari, MD is a Psychiatry healthcare provider based in Falls Church, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477574549.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Husam Alathari, MD has received a total of $67,165 in payments from pharmaceutical and medical device companies, with $4,103 received in 2024. These payments were reported across 238 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($45,750).
As a Medicare-enrolled provider, Alathari has provided services to 2,551 Medicare beneficiaries, totaling 6,231 services with total Medicare billing of $461,697. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Falls Church, VA
- Active Since 07/22/2006
- Last Updated 08/18/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1477574549
Products in Payments
- VRAYLAR (Drug) $19,737
- Vivitrol 380 mg (Drug) $14,542
- ARISTADA (Drug) $12,981
- VIVITROL (Drug) $8,599
- SUBLOCADE (Drug) $5,489
- NEUROSTAR TMS THERAPY SYSTEM (Device) $902.26
- Vivitrol (Drug) $748.73
- SPRAVATO (Drug) $286.78
- REXULTI (Drug) $282.94
- LATUDA (Drug) $235.69
- ABILIFY MAINTENA (Drug) $192.88
- CAPLYTA (Drug) $159.79
- Quillichew ER (Drug) $124.32
- VYVANSE (Drug) $123.93
- AUSTEDO (Drug) $84.35
- INVEGA SUSTENNA (Drug) $78.11
- Qelbree (Drug) $58.38
- INGREZZA (Drug) $55.56
- WELLBUTRIN (Drug) $54.48
- Fanapt (Drug) $45.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Falls Church
Niku Singh, Md, MD
Psychiatry — Payments: $2.7M
Psychiatry $2.7M
Michael Clark, M.d, M.D
Psychiatry — Payments: $18,037
Psychiatry $18,037
Huong Dang, Md, MD
Psychiatry — Payments: $5,669
Psychiatry $5,669
Arthur Mode, Md, MD
Psychiatry — Payments: $1,569
Psychiatry $1,569
Dr. Aleya Karim, M.d, M.D
Psychiatry — Payments: $1,481
Psychiatry $1,481
Dr. Samina Zaidi, M.d, M.D
Psychiatry — Payments: $1,226
Psychiatry $1,226